GLA and Fabry disease: A CRISPR/Cas9-mediated knockout of the GLA gene together with the overexpression of a number of different mutant variants allowed establishing a correlation between enzyme activity levels and ER retention [54] and, thereby, furthered the understanding of the full clinical presentation of Fabry disease.